Similarly, the ITSS grades of IDH1-mutated gliomas were much lower than those of Wild-type gliomas (p < 0.001), and the ITSS grades of MGMT-methylated gliomas were much lower than those of MGMT-unmethylated gliomas (p < 0.001). This evidence concerns the gene IDH1 and central nervous system cancer.